- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05330195
Bicycle Ergometer Training in Duchenne Muscular Dystrophy (BETDMD)
October 10, 2023 updated by: Numan Bulut, Hacettepe University
The Effects of Bicycle Training on Gait and Balance in Children With Duchenne Muscular Dystrophy
The progressive muscle weakness and contractures of the patients adversely affect their gait and balance.
It is known that the disorder of the patients' balance and gait affects their functional capacity.
The aim of this study is to examine the effects of bicycle ergometer training on gait and balance in children with Duchenne Muscular Dystrophy.
Twenty-four children with DMD included in the study will be divided into two groups as home program and home program+bicycle ergometer training with block randomization method.
Home program including stretching, respiratory, range of motion, posture and mild resistance exercise with body weight will be asked to apply 3-5 days a week for 12 weeks, aerobic training will be performed 3 days a week for 12 weeks at 60% of their maximum hearth rate with 40 minutes total duration consisting of 5 min warm up and 5 min cool down period.
Gait and balance were evaluated with GAITrite and Bertec Balance Check Screener, successively.
Assessments will be applied at pre-training and after 12 weeks of training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Altındağ
-
Ankara, Altındağ, Turkey, 06100
- Hacettepe University, Faculty of Physical Therapy and Rehabilitation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 8 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Children have diagnosis of DMD confirmed by genetic analysis,
- Children can walk with unsupported.
Exclusion criteria:
- Children have undergone any surgery or suffered injury of the lower limbs,
- Children have severe contractures of lower limbs,
- Children have low cooperation
- Children have comorbid disease,
- Children were applied regular aerobic training such as bicycle training and hydrotherapy in last 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment Group
Home exercise program Children will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do these for 3 to 5 days a week.
Also, aerobic training will be performed 3 days a week for 12 weeks at 60% of their maximum hearth rate with 40 minutes total duration consisting of 5 min warm up and 5 min cool down period to children in treatment group
|
Bicycle ergometer training will be performed 3 days a week for 12 weeks at 60% of their maximum hearth rate with 40 minutes total duration consisting of 5 min warm up and 5 min cool down period to children in treatment group.
Children will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do these for 3 to 5 days a week.
|
|
Active Comparator: Control Group
Home Based Exercise Group Children will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do this program for 3-5 days a week.
|
Children will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do these for 3 to 5 days a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Step Time and Cycle Time(Gait)
Time Frame: 5 minutes
|
The gait of patients with DMD was assessed by GAITrite (CIR Systems Inc., Franklin, New Jersey, USA) electronic walkway system, objective assessment of spatio-temporal characteristics of gait, at a self-selected speed for 3 times.
With this walkway system, ambulation time (s) was evaluated.
|
5 minutes
|
|
Step Length, Stride Length and base of support (Gait)
Time Frame: 5 minutes
|
The gait of patients with DMD was assessed by GAITrite (CIR Systems Inc., Franklin, New Jersey, USA) electronic walkway system, objective assessment of spatio-temporal characteristics of gait, at a self-selected speed for 3 times.
With this walkway system,step length (cm), stride length (cm) and base of support (cm) were evaluated.
|
5 minutes
|
|
Single support, double support, swing phase and stance phase (Gait)
Time Frame: 5 minutes
|
The gait of patients with DMD was assessed by GAITrite (CIR Systems Inc., Franklin, New Jersey, USA) electronic walkway system, objective assessment of spatio-temporal characteristics of gait, at a self-selected speed for 3 times.
With this walkway system, single support, double support, swing phase and stance phase were stated as %.
|
5 minutes
|
|
Velocity (Gait)
Time Frame: 5 minutes
|
The gait of patients with DMD was assessed by GAITrite (CIR Systems Inc., Franklin, New Jersey, USA) electronic walkway system, objective assessment of spatio-temporal characteristics of gait, at a self-selected speed for 3 times.
With this walkway system, Velocity (cm/s) was evaluated.
|
5 minutes
|
|
Cadence (Gait)
Time Frame: 5 minutes
|
The gait of patients with DMD was assessed by GAITrite (CIR Systems Inc., Franklin, New Jersey, USA) electronic walkway system, objective assessment of spatio-temporal characteristics of gait, at a self-selected speed for 3 times.
With this walkway system, cadence (steps/min) was recorded.
|
5 minutes
|
|
Balance (rigid surface)
Time Frame: 10 minutes
|
The balance plate system used to assess balance and degree of postural sway was the Bertec Balance Check Screener™ (BP5050 Bertec Co., Columbus, OH, USA).
The system consists of a 20 × 20-inch platform at ground level connected to a computer.
Postural sway, which measures the displacement of the center of gravity, was assessed on rigid surface, in 2 conditions (eyes opened-closed) and 2 directions (anteroposterior and mediolateral).
|
10 minutes
|
|
Balance (perturbated surface)
Time Frame: 10 minutes
|
The balance plate system used to assess balance and degree of postural sway was the Bertec Balance Check Screener™ (BP5050 Bertec Co., Columbus, OH, USA).
The system consists of a 20 × 20-inch platform at ground level connected to a computer.
Postural sway, which measures the displacement of the center of gravity, was assessed on perturbated surface, in 2 conditions (eyes opened-closed) and 2 directions (anteroposterior and mediolateral).
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 18, 2022
Primary Completion (Actual)
February 28, 2023
Study Completion (Actual)
May 25, 2023
Study Registration Dates
First Submitted
March 31, 2022
First Submitted That Met QC Criteria
April 8, 2022
First Posted (Actual)
April 15, 2022
Study Record Updates
Last Update Posted (Actual)
October 11, 2023
Last Update Submitted That Met QC Criteria
October 10, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Duchenne Muscular Dystrophy
-
Dyne TherapeuticsRecruitingMuscular Dystrophies | Muscular Dystrophy, Duchenne | Duchenne Muscular Dystrophy (DMD) | Muscular Dystrophy, Duchenne and Becker Types | Genetic Disease, X-Linked | Genetic Disease, Inborn | DMD | Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Muscular Dystrophy (DMD) | Muscular Dystrophies... and other conditionsUnited States
-
Cairo UniversityCompletedMuscular Dystrophy, Duchenne TypeEgypt
-
Medical University of GdanskRecruitingDuchenne Muscular Dystrophy (DMD)Poland
-
PepGen IncWithdrawnDuchenne Muscular Dystrophy (DMD)United Kingdom
-
ItalfarmacoCompletedDuchenne Muscular Dystrophy (DMD)Italy
-
Santhera PharmaceuticalsTerminatedDuchenne Muscular Dystrophy (DMD)United States, Spain, Netherlands, Sweden, Germany, France, Belgium, United Kingdom, Italy, Ireland, Switzerland, Austria, Bulgaria, Hungary, Israel
-
Sarepta Therapeutics, Inc.CompletedDuchenne Muscular Dystrophy (DMD)United States
-
Hospital RudolfstiftungOesterreichische MuskelforschungCompletedCarrier of Duchenne Muscular DystrophyAustria
-
General Hospital of Chinese Armed Police ForcesUnknownDuchenne Muscular Dystrophy (DMD)China
-
Chaitanya Hospital, PuneUnknownMuscular Dystrophy | Duchenne Muscular Dystrophy,India
Clinical Trials on Bicycle Ergometer Training
-
University Hospital, BonnGerman Sport University, CologneCompletedEnd Stage Renal Failure on DialysisGermany
-
Medical University of ViennaUnknownPrehabilitation
-
Hitit UniversityHacettepe UniversityRecruitingHeart Failure With Reduced Ejection FractionTurkey
-
Oberwaid AGUniversity of Zurich; University of Basel; Institute for Exercise and Health...CompletedDepression | Sleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep Fragmentation | Insomnia Due to Other Mental Disorder | Insomnia, Psychophysiological | Insomnia Related to Another Mental ConditionSwitzerland
-
Hacettepe UniversityActive, not recruitingCritical Illness | ICU PatientsTurkey (Türkiye)
-
Rana ElbannaRecruiting
-
Sahmyook UniversityCompletedStroke | Sarcopenia | Muscle Atrophy | Mobility Limitation | Muscle Quality | Robotic RehabilitationSouth Korea
-
Hiroshima UniversityCompleted
-
Firat UniversityRecruitingRheumatoid Arthritis (RA | 6 Minutes Stepper TestTurkey
-
Vastra Gotaland RegionGöteborg UniversityCompletedHypermobile Ehlers-Danlos Syndrome | Joint Hypermobility SyndromeSweden